Only the job description changed.
| Previous Job Description | Current Job Description | ||||
|---|---|---|---|---|---|
| n | 1 | Job Description: | n | 1 | Job Summary: |
| 2 | Job Summary: The R2D2 TB Network (r2d2tbnetwork.org) is an international research consortium focused | ||||
| > | on accelerating the development, validation, and adoption of new tuberculosis diagnostics. The R2D2 | ||||
| > | Team is a multi-institution collaboration with academic and public health partners across the globe | ||||
| > | , including UCSF, UC Irvine, and Heidelberg University, to conduct GCP-compliant, multi-site diagnos | ||||
| > | tic accuracy studies in high TB-burden countries. The Clinical Trial Manager for the R2D2 TB Network | ||||
| > | will apply extensive knowledge of GCP-compliant clinical research protocols and processes to lead, | ||||
| > | manage, and coordinate the conduct and reporting of multicentric tuberculosis diagnostic accuracy st | ||||
| > | udies across international sites in Africa and Asia. The Clinical Trial Manager will: Act as the pri | ||||
| > | mary cross-functional liaison across the adult and pediatric cohorts, connecting the Technology, GCP | ||||
| > | Compliance, Data, and Clinical Support teams with international study sites and sub-contractors to | ||||
| > | ensure aligned communication and accountability. Drive overall study management by overseeing timeli | ||||
| > | nes, tracking milestones, and proactively identifying, documenting, and escalating operational risks | ||||
| > | with timely mitigation plans. Ensure regulatory and quality compliance by overseeing adherence to e | ||||
| > | thics standards, GCP requirements, and the R2D2 TB Network quality management framework, including i | ||||
| > | dentification, documentation, and escalation of protocol deviations and quality findings with approp | ||||
| > | riate corrective and preventive action. Own the development, review, and continuous improvement of s | ||||
| > | tudy procedures, SOPs, and QMS documents supporting GCP, ISO 14155, and ISO 20916 compliance, partne | ||||
| > | ring with the GCP lead to design these systems and with cohort leads to operationalize them at the s | ||||
| > | tudy level, while driving process improvement and embedding a culture of quality across the network. | ||||
| > | Direct the preparation of study reports, regulatory submissions, and internal documentation, ensuri | ||||
| > | ng study records are maintained accurately and in line with data management and archiving requiremen | ||||
| > | ts. Department Summary: The UCSF Center for Tuberculosis (CTB) unites a multidisciplinary community | ||||
| > | of TB experts working to accelerate global TB elimination and train the next generation of TB scient | ||||
| > | ists. Since launching in 2019, CTB has grown to include more than 50 faculty investigators across UC | ||||
| > | SF and UC Berkeley, spanning immunology, data science, epidemiology, pharmacology, diagnostics, ther | ||||
| > | apeutics, biostatistics, implementation science, and policy. As the operational hub of the NIH P30-f | ||||
| > | unded UC Tuberculosis Research Advancement Center, CTB serves as the scientific home for the TB rese | ||||
| > | arch enterprise at UCSF and beyond. Through cooperative scholarship, technical training, mentorship, | ||||
| > | clinical excellence, advocacy, and a collaborative spirit, CTB-affiliated faculty, fellows, and sta | ||||
| > | ff are advancing global health and improving the lives of TB-affected communities through transforma | ||||
| > | tive research and practice. The Institute for Global Health Sciences (IGHS) is a UCSF campus wide in | ||||
| > | terdisciplinary program that reports to the Chancellor. IGHS is structured as an Organized Research | ||||
| > | Unit (ORU) and control point that oversees a portfolio of $330M in sponsored programs (including $80 | ||||
| > | -90M per year in grants and cooperative agreements expenses), two graduate groups that confer Master | ||||
| > | s and PhD degrees, and an administrative unit that provides communication, financial management, eve | ||||
| > | nt planning, staffing support, operations, and program development support to faculty members workin | ||||
| > | g in global health across the campus. IGHS's mission is to advance health and reduce health disparit | ||||
| > | ies worldwide, with a focus on vulnerable populations. IGHS is continuing to expand its programmatic | ||||
| > | activities into new regions (Latin America and Asia) and new themes (e.g., transdisciplinary resear | ||||
| > | ch in infectious disease, maternal and child health, and non-communicable diseases, pandemic prepare | ||||
| > | dness, digital health, climate change, and migrant health). It also is working to develop new educat | ||||
| > | ional program offerings (degree and certificate) and partnerships with academic institutions in the | ||||
| > | US and in low- and middle-income (LMIC) countries. It also has engagements domestically with public | ||||
| > | health programs, including the California Department of Public Health. IGHS is committed to ensuring | ||||
| > | a diverse, equitable and inclusive work environment as we work towards becoming an anti-racist orga | ||||
| > | nization. We strongly encourage applicants from diverse backgrounds. Please see our statement on ant | ||||
| > | i-racism here: https://globalhealthsciences.ucsf.edu/about-us/diversity-equity-and-inclusion/stateme | ||||
| > | nt-structural-racism | ||||
| 3 | 2 | ||||
| t | 4 | Qualifications: | t | 3 | The R2D2 TB Network (r2d2tbnetwork.org) is an international research consortium focused on accelera |
| > | ting the development, validation, and adoption of new tuberculosis diagnostics. The R2D2 Team is a m | ||||
| > | ulti-institution collaboration with academic and public health partners across the globe, including | ||||
| > | UCSF, UC Irvine, and Heidelberg University, to conduct GCP-compliant, multi-site diagnostic accuracy | ||||
| > | studies in high TB-burden countries. | ||||
| 5 | Required: - Bachelor's degree in related area and five years of experience or equivalent experience | 4 | |||
| > | / training. - Expert knowledge of GxP (GCP, GLP, GCLP) and thorough understanding of the ethical and | ||||
| > | regulatory framework governing human subjects research. - Advanced knowledge of clinical research p | ||||
| > | ractices and philosophy, and ability to apply knowledge and skills to recommend improvements in meth | ||||
| > | odology. Advanced knowledge of regulatory requirements. - Advanced ability to effectively lead one o | ||||
| > | r more projects with competing priorities to meet the demands of a fast-paced and dynamic internatio | ||||
| > | nal work environment. Adaptable to quickly changing priorities. - Proven ability to coordinate compl | ||||
| > | ex, multi-site international studies: skilled in tracking deliverables, managing competing prioritie | ||||
| > | s, and maintaining clear documentation and audit trails. - In-depth critical thinking skills to eval | ||||
| > | uate issues and identify potential solutions. Creatively addresses complex or new problems. - Advanc | ||||
| > | ed communication skills, including verbal and written English; active listening, critical thinking, | ||||
| > | persuasiveness, advising, and counseling skills. Clear and concise communicator; culturally responsi | ||||
| > | ve and collaborative. - Advanced interpersonal skills, including problem-solving, teamwork developme | ||||
| > | nt, and leadership with other team members; ability to build effective working relationships across | ||||
| > | diverse, international teams. - Proven ability to perform all commonly applicable functions in word | ||||
| > | processing and spreadsheet software. Advanced knowledge of clinical information and documentation ap | ||||
| > | plication programs. Proven ability utilizing clinical trial management systems. - In-depth ability t | ||||
| > | o work collaboratively with other cross-functional teams; ability to interface, collaborate, and inf | ||||
| > | luence/persuade other members of an extended, multi-institution study team. Preferred: - Postgraduat | ||||
| > | e qualification in a relevant field (e.g., Public Health, Epidemiology, Biomedical Science, or equiv | ||||
| > | alent) and at least 3 years of demonstrated experience managing international, GCP-compliant clinica | ||||
| > | l studies. - Sound understanding of infectious diseases, particularly tuberculosis, including releva | ||||
| > | nt diagnostic tools, public health context, and evolving trends in the field. - Familiarity with ISO | ||||
| > | 20916 and ISO 14155 standards for performance evaluation of in vitro diagnostic medical devices and | ||||
| > | clinical investigation of medical devices. - Experience in diagnostic accuracy studies for infectio | ||||
| > | us diseases. | ||||
| 5 | The Clinical Trial Manager for the R2D2 TB Network will apply extensive knowledge of GCP-compliant | ||||
| > | clinical research protocols and processes to lead, manage, and coordinate the conduct and reporting | ||||
| > | of multicentric tuberculosis diagnostic accuracy studies across international sites in Africa and As | ||||
| > | ia. The Clinical Trial Manager will: | ||||
| 6 | * Act as the primary cross-functional liaison across the adult and pediatric cohorts, connecting th | ||||
| > | e Technology, GCP Compliance, Data, and Clinical Support teams with international study sites and su | ||||
| > | b-contractors to ensure aligned communication and accountability. | ||||
| 7 | * Drive overall study management by overseeing timelines, tracking milestones, and proactively iden | ||||
| > | tifying, documenting, and escalating operational risks with timely mitigation plans. | ||||
| 8 | * Ensure regulatory and quality compliance by overseeing adherence to ethics standards, GCP require | ||||
| > | ments, and the R2D2 TB Network quality management framework, including identification, documentation | ||||
| > | , and escalation of protocol deviations and quality findings with appropriate corrective and prevent | ||||
| > | ive action. | ||||
| 9 | * Own the development, review, and continuous improvement of study procedures, SOPs, and QMS docume | ||||
| > | nts supporting GCP, ISO 14155, and ISO 20916 compliance, partnering with the GCP lead to design thes | ||||
| > | e systems and with cohort leads to operationalize them at the study level, while driving process imp | ||||
| > | rovement and embedding a culture of quality across the network. | ||||
| 10 | * Direct the preparation of study reports, regulatory submissions, and internal documentation, ensu | ||||
| > | ring study records are maintained accurately and in line with data management and archiving requirem | ||||
| > | ents. | ||||
| 11 | |||||
| 12 | Department Summary: | ||||
| 13 | |||||
| 14 | The UCSF Center for Tuberculosis (CTB) unites a multidisciplinary community of TB experts working t | ||||
| > | o accelerate global TB elimination and train the next generation of TB scientists. Since launching i | ||||
| > | n 2019, CTB has grown to include more than 50 faculty investigators across UCSF and UC Berkeley, spa | ||||
| > | nning immunology, data science, epidemiology, pharmacology, diagnostics, therapeutics, biostatistics | ||||
| > | , implementation science, and policy. As the operational hub of the NIH P30-funded UC Tuberculosis R | ||||
| > | esearch Advancement Center, CTB serves as the scientific home for the TB research enterprise at UCSF | ||||
| > | and beyond. Through cooperative scholarship, technical training, mentorship, clinical excellence, a | ||||
| > | dvocacy, and a collaborative spirit, CTB-affiliated faculty, fellows, and staff are advancing global | ||||
| > | health and improving the lives of TB-affected communities through transformative research and pract | ||||
| > | ice. | ||||
| 15 | |||||
| 16 | The Institute for Global Health Sciences (IGHS) is a UCSF campus wide interdisciplinary program tha | ||||
| > | t reports to the Chancellor. IGHS is structured as an Organized Research Unit (ORU) and control poin | ||||
| > | t that oversees a portfolio of $330M in sponsored programs (including $80-90M per year in grants and | ||||
| > | cooperative agreements expenses), two graduate groups that confer Masters and PhD degrees, and an a | ||||
| > | dministrative unit that provides communication, financial management, event planning, staffing suppo | ||||
| > | rt, operations, and program development support to faculty members working in global health across t | ||||
| > | he campus. | ||||
| 17 | |||||
| 18 | IGHS's mission is to advance health and reduce health disparities worldwide, with a focus on vulner | ||||
| > | able populations. IGHS is continuing to expand its programmatic activities into new regions (Latin A | ||||
| > | merica and Asia) and new themes (e.g., transdisciplinary research in infectious disease, maternal an | ||||
| > | d child health, and non-communicable diseases, pandemic preparedness, digital health, climate change | ||||
| > | , and migrant health). It also is working to develop new educational program offerings (degree and c | ||||
| > | ertificate) and partnerships with academic institutions in the US and in low- and middle-income (LMI | ||||
| > | C) countries. It also has engagements domestically with public health programs, including the Califo | ||||
| > | rnia Department of Public Health. | ||||
| 19 | |||||
| 20 | IGHS is committed to ensuring a diverse, equitable and inclusive work environment as we work toward | ||||
| > | s becoming an anti-racist organization. We strongly encourage applicants from diverse backgrounds. P | ||||
| > | lease see our statement on anti-racism here: https://globalhealthsciences.ucsf.edu/about-us/diversit | ||||
| > | y-equity-and-inclusion/statement-structural-racism | ||||